A pharmaceutical company targeting unmet clinical needs.

Herantis Pharma was created by a merger of two pharmaceutical companies, Hermo Pharma and Laurantis Pharma.

Pipeline

Overview

Herantis has a product development portfolio focused in areas of unmet clinical need, based on internationally recognized science.

Read More

Interim report January 1-June 30, 2015: Financially stable - new investments in regenerative medicine: CDNF and Lymfactin

Interim report January 1-June 30, 2015 (unaudited) Highlights in January-June 2015: Tekes, the Finnish Funding Agency for Innovation, granted a…

Read More

Herantis Pharma Certified Adviser change

Herantis Pharma Certified Adviser change Herantis Pharma Plc Company release 1 July 2015 at 10:00 am The shares of Herantis…

Read More

Herantis Pharma granted almost 3 million Euro government loan for Parkinson study

Herantis Pharma granted almost 3 million Euro government loan for Parkinson study Herantis Pharma Plc Company release 30 June 2015…

Read More

Investors

Herantis shares are listed on NASDAQ OMX Helsinki First North Finland. Read More

New therapies for a better life.